Foghorn therapeutics to participate in two upcoming virtual investor conferences

Cambridge, mass., sept. 01, 2021 (globe newswire) -- foghorn therapeutics inc. (nasdaq: fhtx), a clinical stage biotechnology company pioneering a new class of medicines that modulate gene expression through selectively targeting the chromatin regulatory system, today announced that foghorn management will participate in two upcoming virtual investor conferences.
FHTX Ratings Summary
FHTX Quant Ranking